Nobody said the ceiling was real

The Other $85 Trillion series | redebuter.com

I was working for Coca-Cola when Innocent launched, and it caused a genuine panic. Here was a tiny, un-glamorous brand charging something like three times the price of a can of Coke for a bottle sitting in the same fridge — and still taking meaningful share in impulse. The response was to develop concepts of our own: real-fruit smoothie concepts, unbranded at first, with Minute Maid the obvious house for them if they'd gone anywhere. They didn't. The commercial team looked properly at what we'd built and concluded, correctly, that it couldn't work inside our model. Syrup and carbonated water could be produced and shipped at the volumes and margins the whole system was built around. Whole crushed fruit couldn't. The concepts were killed before they reached a shelf.

Coca-Cola bought Innocent instead. A minority stake in 2009, majority by 2010, full control by 2013. And then it did the one thing it has always done better than almost anyone: took a good product and put it everywhere.

Nobody in that room was wrong. That's what I've come to think is the interesting part. The commercial team weren't blind or timid — they were looking at a genuinely real constraint. Coca-Cola's entire architecture, from concentrate to bottler to shelf, was built around a product that behaves nothing like whole fruit. The ceiling on what the model could absorb wasn't a belief anyone needed talking out of. It was true, for us, in a way it simply wasn't true for three people working out of a market stall.

That's the pattern worth pulling apart. Every mature category settles on a price nobody quite decided on — what a mixer costs, what a vodka costs, what a cooler costs. Nobody votes on it. It's just what the category has always charged, and everyone competing inside it, including plenty of smart people, starts treating that number as a fact about the world rather than a habit the market has fallen into. Sometimes an outsider comes along who doesn't know the rule, or doesn't accept it applies to them, and discovers the ceiling was never load-bearing. And sometimes, like the concepts we killed at Coke, the ceiling turns out to be entirely real — just not for them. It's real for you, because of the model you're standing inside.

Three companies worth looking at properly.

Fever-Tree: the ingredient was the argument

Charles Rolls had already done this once. He'd built his career reviving Plymouth Gin before selling it to Absolut in 2001, so when he and advertising executive Tim Warrillow founded Fever-Tree in 2004, he wasn't approaching mixers as a mixer person would. Gin was in the middle of a genuine renaissance — new distilleries, new interest, drinkers paying real attention to what they were drinking for the first time in decades. And every one of those carefully made gins was still being poured over a tonic water built around cheap sweeteners and minimal thought, because tonic had always been an afterthought and nobody serious had questioned that.

The insight wasn't really a marketing insight. It was named directly into the product. "Fever-Tree" is the colloquial name for the cinchona tree, the actual botanical source of quinine — the ingredient that makes tonic water taste of anything at all. Rolls and Warrillow went looking for cinchona bark in the Democratic Republic of Congo and built a tonic around real quinine and natural botanicals rather than the artificial approximations the category had settled on. The premium wasn't a story wrapped around an ordinary product. The ingredient was the argument.

It worked, and it kept working for two decades. Fever-Tree listed on the London Stock Exchange in 2014 and grew into the clear leader in premium mixers, with group revenue reaching £368.5 million in 2024, the US now its largest market by some distance.

Grey Goose: refusing to compete on the existing scale

Sidney Frank had already turned a cheap German digestif into a fixture of American college bars, so by the time he looked seriously at vodka in the mid-1990s, he had a fair amount of confidence that a category's accepted price wasn't a law of physics. Absolut, at the time the undisputed premium leader, sold for around $17 a bottle — a price the whole category had organised itself around. Frank didn't try to beat that price or match it. He launched Grey Goose at $30, built a backstory to justify the number rather than the other way round, and sourced the whole thing from France: wheat from Picardy, water filtered through Champagne limestone, a maître de chai borrowed from Cognac production. Vodka doesn't need any of that to taste of anything in particular — Frank knew this — but the story was never really about flavour. It was about giving people a reason the price made sense.

It worked, fast. By 2004, eight years after the idea started, Bacardi bought Grey Goose for a reported $2.2 billion, by some estimates close to $2.4 billion — at the time the largest sum ever paid for a single liquor brand, and Grey Goose was reportedly controlling the large majority of the entire super-premium vodka category it had created. One line from the brand's own history sums up what Frank actually did better than any case study could: unlike the competitors around him, who were still playing by the pricing rules of the category they were in, Frank set out from the start to be a category of one.

YETI: the mispriced cooler

Roy and Ryan Seiders grew up in Texas hunting and fishing, and by the mid-2000s they'd both run through enough cheap coolers that failed exactly when it mattered — cracked hinges, lids that didn't seal, ice gone by the second day — to start wondering why nobody had ever built one properly. In 2006 they founded YETI on a simple bet: that a cooler was a fundamentally mispriced object, sitting at $20-30 because that's what coolers had always cost, not because that's what a genuinely well-built one needed to cost. They borrowed rotomoulding, a manufacturing technique lifted from kayak production, to build coolers that could survive being sat on by a bear and still hold ice for days. They priced them at $300 to $700.

It worked on a scale that outran even Fever-Tree and Grey Goose. YETI listed on the New York Stock Exchange in 2018 and reported net sales of roughly $1.8 billion for fiscal 2024, growing again into 2025, with drinkware — the Rambler line that grew out of the same design obsession — now making up more than half of revenue. It's the cleanest version of this pattern because there's nothing glamorous about the underlying category at all. A cooler is about as unpromising a canvas for premiumisation as consumer goods offers, and it still worked.

The pattern, and where luck fits

None of these three had a starting position anyone else lacked access to. What they had was a specific, structural reason to doubt that the category's price was actually fixed — an outsider's eye from a previous industry, a manufacturing technique borrowed from somewhere else entirely, a piece of ingredient knowledge the category itself had simply stopped bothering with. That's the transferable part, and it's a genuinely useful question to sit with about your own category: what has everyone here simply stopped questioning, not because it was ever settled, but because nobody's checked in a long time?

It would be dishonest to leave out timing. Frank landed in vodka just as American cocktail culture was rediscovering itself through Sex and the City and the affluent nightlife scene he specifically targeted. Rolls and Warrillow launched Fever-Tree into the exact decade gin was staging its comeback. The Seiders brothers built YETI just as an entire generation started treating outdoor identity as something worth paying for, then broadcasting on social media. None of the three could have engineered that timing on purpose. What they could do — and did — was build something specific enough that when the moment arrived, they were standing in exactly the right place to catch it.

And the Innocent story is the other half of the same coin, the one that doesn't get told as often. Sometimes the ceiling really is real — not because anyone's imagination failed, but because the whole apparatus you're operating inside was built for a different product entirely. Clayton Christensen described this structurally decades ago: well-run companies aren't usually undone by stupidity, they're undone by being extremely good at a model that can't flex toward the thing that's about to matter. Knowing that doesn't make the ceiling any less real from inside the room. It just tells you what your actual options are once you've correctly identified it: change the model, at real cost and real risk, or go and buy the capability from whoever built it outside your walls. Coca-Cola chose the second.

The thing I didn't expect

The thing I didn't expect when I started checking this properly is that the bump doesn't line up neatly with elapsed time — it lines up much more precisely with a change in who the company is answering to.

Fever-Tree floated on the London Stock Exchange in 2014. The share price didn't wobble for years; the real trouble started around 2018, roughly four years after going public, once quarterly scrutiny met a maturing growth rate. The shares had peaked at a valuation close to £5 billion and have spent the years since falling to a fraction of that, the company needing a partnership with Molson Coors in 2025 just to get proper distribution muscle in its own largest market.

YETI followed almost exactly the same shape. It listed on the New York Stock Exchange in 2018, and within five years — a magnet-closure safety recall covering close to 1.9 million units, notified to regulators in January 2023, plus a first-ever decline in US drinkware sales and a shelf increasingly crowded by Stanley and RTIC — it was defending the ceiling it had broken rather than expanding it.

Grey Goose and Innocent complicate the pattern rather than confirm it, which is worth being honest about rather than smoothing over. Grey Goose's difficulty isn't really a bump in Grey Goose at all: the brand has, by most accounts, held its position reasonably well under Bacardi, even as the wider vodka category has cooled since 2023. The actual complication is that nobody else has managed to repeat Frank's trick since, in any spirits category — which says more about how rare the original alignment of story, timing and craft was than about the company running into trouble years later.

Innocent's crisis ran in the opposite direction entirely. The 2008 financial crash very nearly finished the company — sales fell by close to 30% across 2008 and 2009, the business posted an £8.6 million loss, and by the founders' own account they ended 2008 with £2.3 million in cash against £21.7 million owed. The Coca-Cola stake in 2009 wasn't a reward arriving years after success. It was the rescue that arrived because the company hadn't yet built anything resilient enough to survive a genuine external shock, roughly ten years after founding.

So the honest version of this second theme is narrower than "these things go wrong on a schedule." What's actually true, in two of the four cases, is that going public seems to expose weaknesses within four to five years that private ownership had quietly absorbed. The other two are reminders that the ceiling can also turn out to be very hard for anyone else to break in the same way (Grey Goose), or that it can nearly finish you before most people have heard of you at all (Innocent).

Either way, it's a different piece to this one — what actually happens to a challenger in the years after it wins, and how much of that has to do with who it's now answering to. This one is about how the ceiling gets broken in the first place.

Every one of these categories had smart, well-resourced incumbents in it before the challenger turned up. None of them were stupid. They'd just stopped asking whether the price they'd all agreed on was actually true, or just familiar.

For now, though, maybe it's worth reflecting on where the price ceiling sits in your own category — and who's quietly propping it up.

Sources: Fever-Tree company history and financial reporting (Wikipedia; Fever-Tree FY2024 results; BeverageDaily, "Molson Coors takes 8.5% stake in Fever-Tree", February 2025); Grey Goose brand history (Wikipedia; The Spirits Business, "Grey Goose: a brand history"; Forbes obituary of Sidney Frank, 2006; The Spirits Business, "World Spirits Report 2025: Vodka"; ILBA, "Vodka Weathers The Storm", 2025; CityAM, "Bacardi: Martini maker shaken as drinkers move away from spirits", 2025); YETI Holdings company history and SEC filings (YETI FY2024 8-K and 10-Q filings, SEC EDGAR; CPSC recall notices, January-March 2023; Gear Patrol, "Yeti Recalls Nearly Two Million Soft Coolers and Gear Cases"); Innocent Drinks ownership and 2008-09 financial history (Wikipedia; The Guardian, "Coca-Cola takes full control of Innocent", February 2013; The Ecologist, "Green Business: Innocent", 2011; Nutraceuticals World, "Innocent Drinks Turns to Coca-Cola in Recession"). Clayton M. Christensen, The Innovator's Dilemma (1997).

Part of "The Other $85 Trillion" series | redebuter.com

Tags: Leadership, Innovation, Strategy, Premiumisation, Redebuter